SQUAWK/NEWS
Account
Theme
Account
Menu
Live News EQUITY FLASH L impact

Kiora Pharma Files 424B3

Kiora Pharmaceuticals files prospectus supplement with SEC

KIOR

This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.